0001415889-18-001538.txt : 20181023 0001415889-18-001538.hdr.sgml : 20181023 20181023142844 ACCESSION NUMBER: 0001415889-18-001538 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181011 FILED AS OF DATE: 20181023 DATE AS OF CHANGE: 20181023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABELES JOHN H CENTRAL INDEX KEY: 0000902418 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00935 FILM NUMBER: 181133898 MAIL ADDRESS: STREET 1: 2365 NW 41ST STREET CITY: BOCA RATON STATE: FL ZIP: 33431 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medite Cancer Diagnostics, Inc. CENTRAL INDEX KEY: 0000075439 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 364296006 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 BUSINESS PHONE: 4078490290 MAIL ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 FORMER COMPANY: FORMER CONFORMED NAME: CytoCore Inc DATE OF NAME CHANGE: 20060815 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULAR DIAGNOSTICS INC DATE OF NAME CHANGE: 20011009 FORMER COMPANY: FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP DATE OF NAME CHANGE: 19990527 4 1 form4-10232018_111029.xml X0306 4 2018-10-11 0000075439 Medite Cancer Diagnostics, Inc. MDIT 0000902418 ABELES JOHN H C/O MEDITE CANCER DIAGNOSTICS, INC. 10524 MOSS PARK RD. STE-204-357 ORLANDO FL 32832 true false false false Common Stock 2018-08-13 4 J 0 40000 A 1300185 I Northlea Partners, Ltd. Common Stock 2018-10-11 4 P 0 266667 0.075 A 1566852 I Northlea Partners, Ltd. Common Stock 116350 D 40,000 shares were issued to Northlea Partners, Ltd. for accrued interest on a debt. /s/ John H. Abeles, M.D. 2018-10-23